Fillers: Technics and adverse effects;Matériaux de comblement: Techniques et effets indésirables

EMC - Dermatologie-Cosmetologie

Volumn 1, Issue 1, 2004, Pages 59-74

  Pons Guiraud, A ^a  

^a NONE   (France)

Author keywords

Bovine collagen; Hyaluronic acid; Polylactic acid; Side effects

Indexed keywords

EID: 7444272197     PISSN: 17625696     EISSN: 17625696     Source Type: Journal    
DOI: 10.1016/j.emcdc.2003.12.002     Document Type: Short Survey

References (35)

1. Alster TS, West TB. New options for soft tissue augmentation. Skin Aging 1998:32-36.
2. Balazs EA, Leshchiner EA. Hyaluronan, its cross linked derivative-hylan-and their medical applications. In: Inagaki H, Philips GO, editors. Cellulosics utilisation: research and rewards in cellulosics. Tokyo: Elsevier, Applied Science Publications; 2000. p. 233-241.
3. Barr R, Stegman SJ. Delayed skin test reaction to injectable collagen implant (Zyderm). The histopathologic comparative study. J Am Acad Dermatol 1984;10:652-658.
4. Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann DJ. Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. J Am Acad Dermatol 1989; 21:1203-1208.
5. Clark DP, Hanke CW, Swanson NA. Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol 1989;21:992-998.
6. De Lustro F, Fries J, Kang A, et al. Immunity to injectable collagen and auto-immune disease: a summary of current undestanding. J Dermatol Surg Oncol 1988;14(suppl1): 57-65.
7. Duranti F, Salti G, Bovani B. Injectable hyaluronic acid gel for soft tissue augmentation. Perugia: Angio Dermo Surgery Center; 2000.
8. Elson ML. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol 1989; 15: 301-303.
9. Faure M. Complications des implants de silicone et autres matériaux dits inertes. Ann Dermatol Vénéréol 1995;122: 455-459.
10. Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 1991;25(2Pt1):319-326.
11. Hoffmann C, Schuller-Petrovic S, Soyer HP, Kerl H. Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J Am Acad Dermatol 1999;40:100-102.
12. Kaplan EN, Falces E, Tolleth H. Clinical utilization of injectable collagen. Ann Plast Surg 1983;10:437-451.
13. Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft tissue augmentation. Plast Reconstr Surg 1977;60: 396-405.
14. Klein AW. Injectable collagen gives good cosmetic results in soft-tissue augmentation. Cosmet Dermatol 1992;5: 42-43.
15. Krasteva M, Kehren J, Nicolas JF. Haptènes et cellules dendritiques. Progrès en Dermato-Allergologie. Bruxelles: GERDA; 1999. p. 27-42.
16. Larsen NE, Pollak CT, Reiner K, Balazs EA. Hylan gel biomaterial: dermal and immunologic compatibility. J Briomed Mater Res 1993;27:1129-1134.
17. Lemperle G, Ott H, Charrier U, Hecker J, Lemperle M. PMMA microspheres for intradermal implantation: Part I. Animal research. Ann Plast Surg 1991;26:57-63.
18. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable acid gel. Dermatol Surg 2000;26:135-137.
19. McCoy Jr JP, Schade W, Siegle RJ, Waldinger TP, Vanderveen EE, Swanson NA. Characterization of the humoral immune response to bovine collagen implants. Arch Dermatol 1985;121:990-994.
20. Maas CS, Papel ID, Greene D, Stoker DA. Complications of injectable synthetic polymers in facial augmentation. Dermatol Surg 1997;23:871-877.
21. McCoy Jr JP, Schade W, Siegle RJ, Vanderveen EE, Zachary CB, Waldinger TP, et al. Immune response to bovine collagen implants. Significance of pretreatment serology. J Am Acad Dermatol 1987;16:955-960.
22. Micheels P. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg 2001;27:185-191.
23. Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles and folds. Aesthet Plast Surg 1998;22:97-101.
24. Pearl RM, Laub DR, Kaplan EN. Complications following silicone injections for augmentation of the contours of the face. Plast Reconstr Surg 1978;61:888-891.
25. Piacquadio D. L'acide hyaluronique réticulé (Hylan Gel) utilisé comme produit d'augmentation des tissus mous: estimation préliminaire. J Méd Esthét Chir Dermatol 1996; 23:223-226.
26. Pons-Guiraud A. Réactions d'hypersensibilité retardée aux implants de collagène bovin. Étude sur 810 patients. Nouv Dermatol 1992;11:422-432.
27. Pons-Guiraud A. Place des tests dans les méthodes de comblement des rides. Progrès en Dermato-Allergologie. Bruxelles: GERDA; 2001. p. 251-261.
28. Pons-Guiraud A. Actualisation des effets secondaires des produits de comblement des rides. Nouv Dermatol 2003; 22:202-204.
29. Requena C, Izquierdo MJ, Navarro M, Martinez A, Vilata JJ, Botella R, et al. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol 2001;23:197-202.
30. Rudolph CM, Soyer HP, Schuller-Petrovic S, Kerl H. Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 1999;23:113-117.
31. Schnitzler L, Hartmann DJ, Charriere G. Intradermal bovine collagen implant. Can double test (skin test and anticollagen serologic test) prevent adverse hypersensitivity reaction at treatment sites? 2e congress EADV, Athens, 1991: postern 162:394.
32. Schnitzler L, Baran R, Arrouy M, Dubertret L, Haslan M. Réponses cutanées à l'implant de collagène injectable (Zyderm). Corrélations cliniques, histologiques et ultra-structurales après tests intradermiques. Ann Dermatol Venereol 1984;111:135-145.
33. Silver FH, Glasgold AL. Silicone facial implants: are they safe? J Long Term Effect Med Implants 1993;3:313-320.
34. Tennstedt D, Lachapelle JM. Histopathologie des granulomes tardifs consécutifs aux injections de produits de comblement pour rides (colorations spéciales). 2003.
35. Winer LH, Sternberg TH, Lehman R, Ashley FL. Tissue reactions to injected silicone liquids. A report of three cases. Arch Dermatol 1964;90:588-593.